These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

107 related items for PubMed ID: 1683785

  • 1. Pharmacology and clinical investigation of SR-2508 (etanidazole).
    O'Dwyer PJ, LaCreta FP.
    Cancer Treat Res; 1991; 58():45-63. PubMed ID: 1683785
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Radiosensitization by the combination of etanidazole (SR-2508) and pimonidazole (Ro 03-8799) in human tumor xenografts.
    Taghian A, Lespinasse F, Guichard ME.
    Int J Radiat Oncol Biol Phys; 1991 Nov; 21(6):1535-40. PubMed ID: 1834621
    [Abstract] [Full Text] [Related]

  • 4. The development of an oral prodrug, SR-2545, of the 2-nitroimidazole radiosensitizer SR-2508.
    Coleman CN, Lee WW, Constine LS, Brown JM.
    Int J Radiat Oncol Biol Phys; 1982 Nov; 8(3-4):431-4. PubMed ID: 6213588
    [Abstract] [Full Text] [Related]

  • 5. Radiosensitization efficacy of KU-2285, RP-170 and etanidazole at low radiation doses: assessment by in vitro cytokinesis-block micronucleus assay.
    Shibamoto Y, Streffer C, Sasai K, Oya N, Abe M.
    Int J Radiat Biol; 1992 Apr; 61(4):473-8. PubMed ID: 1349329
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Radiosensitization by hypoxic cell radiosensitizer--present status of radiosensitizer].
    Murayama C, Mori T.
    Gan No Rinsho; 1990 Oct; 36(13):2249-54. PubMed ID: 2147449
    [Abstract] [Full Text] [Related]

  • 8. Radiosensitization by a new nucleoside analogue: 1-[2-hydroxy-1-(hydroxymethyl)ethoxy]methyl-2-nitroimidazole (RP-170).
    Murayama C, Suzuki A, Suzuki T, Miyata Y, Sakaguchi M, Tanabe Y, Tanaka N, Mori T.
    Int J Radiat Oncol Biol Phys; 1989 Sep; 17(3):575-81. PubMed ID: 2528527
    [Abstract] [Full Text] [Related]

  • 9. KIH-802, an acetohydroxamic acid derivative of 2-nitroimidazole, as a new potent hypoxic cell radiosensitizer: radiosensitizing activity, acute toxicity, and pharmacokinetics.
    Sasai K, Shibamoto Y, Takahashi M, Zhou L, Hori H, Nagasawa H, Shibata T, Inayama S, Abe M.
    Cancer Chemother Pharmacol; 1990 Sep; 26(2):112-6. PubMed ID: 2140730
    [Abstract] [Full Text] [Related]

  • 10. Effect of acidic pH on radiosensitization of FSaIIC cells in vitro by misonidazole, etanidazole, or cis-diamminedichloroplatinum (II).
    Herman TS, Teicher BA, Pfeffer MR, Khandekar V, Chapnick RM, Kalick GS, Rabow A.
    Radiat Res; 1990 Oct; 124(1):28-33. PubMed ID: 2146699
    [Abstract] [Full Text] [Related]

  • 11. A fluorinated 2-nitroimidazole, KU-2285, as a new hypoxic cell radiosensitizer.
    Sasai K, Nishimoto S, Shimokawa K, Hisanaga Y, Kitakabu Y, Shibamoto Y, Zhou L, Wang J, Takahashi M, Kagiya T.
    Int J Radiat Oncol Biol Phys; 1991 Jun; 20(6):1249-54. PubMed ID: 1828462
    [Abstract] [Full Text] [Related]

  • 12. Variation in sensitizing efficiency for SR 2508 in human cells dependent on glutathione content.
    Phillips TL, Mitchell JB, de Graff W, Russo A, Glatstein E.
    Int J Radiat Oncol Biol Phys; 1986 Sep; 12(9):1627-35. PubMed ID: 2944860
    [Abstract] [Full Text] [Related]

  • 13. Modification of SR 2508 sensitization in hypoxic V79 cells by manipulation of glutathione levels.
    Phillips TL, Mitchell JB, DeGraff WG, Russo A, Albright N, Rajpal R.
    Int J Radiat Oncol Biol Phys; 1989 May; 16(5):1335-9. PubMed ID: 2523886
    [Abstract] [Full Text] [Related]

  • 14. SR-2508: a 2-nitroimidazole amide which should be superior to misonidazole as a radiosensitizer for clinical use.
    Brown JM, Yu NY, Brown DM, Lee WW.
    Int J Radiat Oncol Biol Phys; 1981 Jun; 7(6):695-703. PubMed ID: 6457018
    [No Abstract] [Full Text] [Related]

  • 15. Comparison of radiosensitizing effect of KU-2285 and SR-2508 at low drug concentrations and doses.
    Shibata T, Shibamoto Y, Oya N, Sasai K, Murata R, Ishigaki T, Abe M.
    Int J Radiat Oncol Biol Phys; 1994 Jun 15; 29(3):587-90. PubMed ID: 8005820
    [Abstract] [Full Text] [Related]

  • 16. Radiosensitizing activity and pharmacokinetics of multiple dose administered KU-2285 in peripheral nerve tissue in mice.
    Iwai H, Matsuno E, Sasai K, Shibamoto Y, Abe M.
    Int J Radiat Oncol Biol Phys; 1994 Jun 15; 29(3):591-4. PubMed ID: 8005821
    [Abstract] [Full Text] [Related]

  • 17. The relationship of SR-2508 sensitizer enhancement ratio to cellular glutathione levels in human tumor cell lines.
    Mitchell JB, Phillips TL, DeGraff W, Carmichael J, Rajpal RK, Russo A.
    Int J Radiat Oncol Biol Phys; 1986 Jul 15; 12(7):1143-6. PubMed ID: 2943712
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Modulation of X ray DNA damage by SR-2508 +/- buthionine sulfoximine.
    Kinsella TJ, Dobson PP, Russo A, Mitchell JB, Fornace AJ.
    Int J Radiat Oncol Biol Phys; 1986 Jul 15; 12(7):1127-30. PubMed ID: 2943711
    [Abstract] [Full Text] [Related]

  • 20. Gradient high-performance liquid chromatographic method for simultaneous assay of the radiosensitizers etanidazole (SR 2508) and pimonidazole (Ro 03-8799) in biological materials.
    Ward R, Workman P.
    J Chromatogr; 1987 Sep 04; 420(1):223-7. PubMed ID: 2959677
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.